Medicine
Sucralfate 1 g tablet
Sucralfate 1 g tablet is a generic prescription medicine for oral use, made by 24 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F).
Key facts
- Active ingredient (INN)
- Sucralfate
- Brand
- Sold under the generic name
- Strength
- 1 g
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 100 tablets, 500 tablets, 30 tablets and 101 more
- Manufacturers
- Viona PharmaceuticalsIndiaZydus LifesciencesIndiaBryant Ranch PrepackAmneal Pharmaceuticals NYTeva PharmaceuticalsChartwell RXMylan PharmaceuticalsMylan Institutional24 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- A02BX02 Sucralfate
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 11 November 1996
- Identifiers
- RxCUI 314234DailyMed set ID 84447e21-e311-4e9f-9065-53956e90135c, 51459cdb-a04a-49c2-8ee4-8f234f522476, 3b0259fa-806f-44c1-8deb-c11dbd84582d +37NDC 71610-017, 82804-102, 0615-8653 +37Application NDA018333, ANDA074415, ANDA215705 +2
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
A sample of 40 packs from 24 labelers. The register lists 104 packs for this generic presentation, and we confirm the exact pack on the quote.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet in 1 bottle | 72578-081-01 | Viona PharmaceuticalsIndia | 20 May 2023 |
| 500 tablet in 1 bottle | 72578-081-05 | Viona PharmaceuticalsIndia | 20 May 2023 |
| 30 tablet in 1 bottle | 72578-081-06 | Viona PharmaceuticalsIndia | 20 May 2023 |
| 100 tablet in 1 bottle | 70771-1833-1 | Zydus LifesciencesIndia | 20 May 2023 |
| 30 tablet in 1 bottle | 70771-1833-3 | Zydus LifesciencesIndia | 20 May 2023 |
| 500 tablet in 1 bottle | 70771-1833-5 | Zydus LifesciencesIndia | 20 May 2023 |
| 100 tablet in 1 bottle | 60219-1656-1 | Amneal Pharmaceuticals NY | 2 March 2024 |
| 500 tablet in 1 bottle | 60219-1656-5 | Amneal Pharmaceuticals NY | 2 March 2024 |
| 100 tablet in 1 bottle | 69238-1656-1 | Amneal Pharmaceuticals NY | 22 April 2022 |
| 500 tablet in 1 bottle | 69238-1656-5 | Amneal Pharmaceuticals NY | 23 May 2022 |
| 100 tablet in 1 bottle | 62135-436-01 | Chartwell RX | 13 March 2023 |
| 90 tablet in 1 bottle | 62135-436-90 | Chartwell RX | 4 November 2022 |
| 100 blister pack in 1 carton / 1 tablet in 1 blister pack | 51079-753-20 | Mylan Institutional | 24 September 2013 |
| 100 tablet in 1 bottle | 59762-0401-1 | Mylan Pharmaceuticals | 25 September 2017 |
| 500 tablet in 1 bottle | 59762-0401-5 | Mylan Pharmaceuticals | 25 September 2017 |
| 100 tablet in 1 bottle | 0093-2210-01 | Teva Pharmaceuticals | 11 November 1996 |
| 500 tablet in 1 bottle | 0093-2210-05 | Teva Pharmaceuticals | 11 November 1996 |
| 90 tablet in 1 bottle | 0093-2210-98 | Teva Pharmaceuticals | 12 January 2011 |
| 28 tablet in 1 bottle | 63629-1307-0 | Bryant Ranch Prepack | 8 November 2022 |
| 100 tablet in 1 bottle | 63629-1307-1 | Bryant Ranch Prepack | 5 February 2007 |
| 60 tablet in 1 bottle | 63629-1307-2 | Bryant Ranch Prepack | 12 April 2010 |
| 30 tablet in 1 bottle | 63629-1307-3 | Bryant Ranch Prepack | 19 September 2008 |
| 20 tablet in 1 bottle | 63629-1307-4 | Bryant Ranch Prepack | 17 October 2013 |
| 150 tablet in 1 bottle | 63629-1307-6 | Bryant Ranch Prepack | 8 November 2022 |
| 90 tablet in 1 bottle | 63629-1307-7 | Bryant Ranch Prepack | 13 September 2010 |
| 40 tablet in 1 bottle | 63629-1307-8 | Bryant Ranch Prepack | 23 February 2012 |
| 120 tablet in 1 bottle | 63629-1307-9 | Bryant Ranch Prepack | 31 May 2013 |
| 100 tablet in 1 bottle, plastic | 63629-9152-1 | Bryant Ranch Prepack | 26 January 2022 |
| 500 tablet in 1 bottle, plastic | 63629-9153-1 | Bryant Ranch Prepack | 26 January 2022 |
| 28 tablet in 1 bottle, plastic | 71335-2114-0 | Bryant Ranch Prepack | 20 June 2022 |
| 100 tablet in 1 bottle, plastic | 71335-2114-1 | Bryant Ranch Prepack | 20 June 2022 |
| 60 tablet in 1 bottle, plastic | 71335-2114-2 | Bryant Ranch Prepack | 20 June 2022 |
| 30 tablet in 1 bottle, plastic | 71335-2114-3 | Bryant Ranch Prepack | 20 June 2022 |
| 20 tablet in 1 bottle, plastic | 71335-2114-4 | Bryant Ranch Prepack | 20 June 2022 |
| 150 tablet in 1 bottle, plastic | 71335-2114-6 | Bryant Ranch Prepack | 20 June 2022 |
| 90 tablet in 1 bottle, plastic | 71335-2114-7 | Bryant Ranch Prepack | 20 June 2022 |
| 40 tablet in 1 bottle, plastic | 71335-2114-8 | Bryant Ranch Prepack | 20 June 2022 |
| 120 tablet in 1 bottle, plastic | 71335-2114-9 | Bryant Ranch Prepack | 20 June 2022 |
| 28 tablet in 1 bottle | 71335-2461-0 | Bryant Ranch Prepack | 3 November 2026 |
| 100 tablet in 1 bottle | 71335-2461-1 | Bryant Ranch Prepack | 3 November 2026 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 30 October 1981 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Sucralfate 1 g tablet.
Other strengths and forms of Sucralfate
Clinical summary
Sucralfate is an aluminum complex indicated to 8 weeks) of active duodenal ulcer. It is available as tablets and oral suspension. MedsAcross supplies Sucralfate for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about SucralfateFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Carafate prescribing information (Allergan) · U.S. National Library of Medicine, DailyMed
Need Sucralfate 1 g tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.